The Hearty Soul on MSN
Why Even Your Skin Can Feel the Effects of High Blood Pressure
High blood pressure is often described as a silent threat inside the body. People typically connect it with heart attacks or ...
Eczema, a chronic skin condition causing itching and inflammation, affects people of all ages. It manifests in various forms like atopic dermatitis and contact dermatitis, often triggered by allergens ...
If approved, EBGLYSS would be a first-line biologic that offers the option of monotherapy with once every eight-week maintenance dosing in moderate-to-severe atopic dermatitis uncontrolled by topicals ...
The MarketWatch News Department was not involved in the creation of this content. TORONTO, Sept. 25, 2025 /CNW/ - Today, Eli Lilly Canada Inc.'s ("Lilly") Ebglyss(R) (lebrikizumab) to treat ...
Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on ...
Dr. Chelsea Dorsey discusses chronic venous insufficiency (CVI) as a debilitating, underdiagnosed disease with high costs and limited treatments, highlighting bioprosthetic venous valves as a ...
Lilo & Stitch actor David Hekili Kenui Bell died on June 12 at the age of 46. The autopsy was performed on June 19 and concluded on July 10. The report revealed that medical intervention was attempted ...
David H.K. Bell suffered with four "pathological diagnoses" at the time of his death, according to his autopsy report. The Lilo and Stitch actor - who was credited as Big Hawaiian Dude in the 2025 ...
Severe thunderstorms are expected to hit parts of Central Florida on Wednesday evening. Hazardous winds and hail are possible. Active Weather AlertsFlood advisory in effect in Seminole County until ...
The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, said Lawrence Eichenfield, MD, chief of pediatric and adolescent ...
LEO Pharma A/S, a global leader in medical dermatology, today announced the positive results from a 16-week interim analysis of the Phase 3b ADHAND trial evaluating tralokinumab for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results